Cargando…

CD105 (Endoglin)-Negative Murine Mesenchymal Stromal Cells Define a New Multipotent Subpopulation with Distinct Differentiation and Immunomodulatory Capacities

Administration of in vitro expanded mesenchymal stromal cells (MSCs) represents a promising therapy for regenerative medicine and autoimmunity. Both mouse and human MSCs ameliorate autoimmune disease in syn-, allo- and xenogeneic settings. However, MSC preparations are heterogeneous which impairs th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Per, Carrillo-Gálvez, Ana Belén, García-Pérez, Angélica, Cobo, Marién, Martín, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790740/ https://www.ncbi.nlm.nih.gov/pubmed/24124603 http://dx.doi.org/10.1371/journal.pone.0076979

Ejemplares similares

Mesenchymal Stromal Cells Express GARP/LRRC32 on Their Surface: Effects on Their Biology and Immunomodulatory Capacity
por: Carrillo-Galvez, Ana Belén, et al.
Publicado: (2015)

ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours
por: Gromova, Petra, et al.
Publicado: (2012)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)

Study of expression of endoglin (CD105) in oral squamous cell carcinoma
por: Mahapatra, Niva, et al.
Publicado: (2021)

Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
por: Kasprzak, Aldona, et al.
Publicado: (2018)

Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
por: Nogués, Ana, et al.
Publicado: (2020)

Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2007)

Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
por: Bock, Annika J., et al.
Publicado: (2011)

Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2020)

Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021)

Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review
por: Sier, Vincent Q., et al.
Publicado: (2021)

Horoscopic role of CD105 (Endoglin) in progression of oral lichen planus: An immunohistochemical study
por: Parvathala, Poornima, et al.
Publicado: (2021)

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
por: Bastos, António G. P., et al.
Publicado: (2022)

Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
por: Fonsatti, Ester, et al.
Publicado: (2004)

PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
por: Mihić, Josip, et al.
Publicado: (2019)

Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review
por: Sur, Daniel, et al.
Publicado: (2022)

Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin
por: Walker, Douglas G., et al.
Publicado: (2019)

Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer
por: Liu, Yingmiao, et al.
Publicado: (2014)

Glioblastoma CD105(+) cells define a SOX2(−) cancer stem cell-like subpopulation in the pre-invasive niche
por: Li, Jiaxin, et al.
Publicado: (2022)

CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma
por: Smith, Stuart J., et al.
Publicado: (2012)

Endoglin (CD105) is a more appropriate marker than CD31 for detecting microvessels in carotid artery plaques
por: Fukumitsu, Ryu, et al.
Publicado: (2013)

Endoglin (CD105) expression differentiates between aseptic loosening and periprosthetic joint infection after total joint arthroplasty
por: Jansen, Philipp, et al.
Publicado: (2014)

A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors
por: Listik, Eduardo, et al.
Publicado: (2021)

Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial
por: Ahluwalia, Manmeet S., et al.
Publicado: (2023)

Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells
por: Rosu-Myles, Michael, et al.
Publicado: (2012)

ACSA‐2 and GLAST classify subpopulations of multipotent and glial‐restricted cerebellar precursors
por: Kantzer, Christina Geraldine, et al.
Publicado: (2021)

Meniscus Regeneration With Multipotent Stromal Cell Therapies
por: Zhou, Yun-Feng, et al.
Publicado: (2022)

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
por: Chen, Pei-Min, et al.
Publicado: (2011)

Anti-Human Endoglin (hCD105) Immunotoxin—Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1
por: Barriuso, Begoña, et al.
Publicado: (2016)

The deubiquitinating enzyme UCHL1 negatively regulates the immunosuppressive capacity and survival of multipotent mesenchymal stromal cells
por: Gu, Yuting, et al.
Publicado: (2018)

CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive Properties
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022)

Lent-On-Plus Lentiviral vectors for conditional expression in human stem cells
por: Benabdellah, Karim, et al.
Publicado: (2016)

Monoclonal anti-endoglin antibody TRC105 (carotuximab) prevents hypercholesterolemia and hyperglycemia-induced endothelial dysfunction in human aortic endothelial cells
por: Tripska, Katarina, et al.
Publicado: (2022)

Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells
por: Ravanidis, Stylianos, et al.
Publicado: (2015)

Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties
por: Yaochite, Juliana Navarro Ueda, et al.
Publicado: (2016)

Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo
por: Cheng, Anastasia, et al.
Publicado: (2020)

Macroscopic, Histologic, and Immunomodulatory Response of Limb Wounds Following Intravenous Allogeneic Cord Blood-Derived Multipotent Mesenchymal Stromal Cell Therapy in Horses
por: Mund, Suzanne J. K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mmajn4ean6c1ndutohntcukuho